Holly Salloga, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 494 Conchester Hwy, Aston, PA 19014 Phone: 610-859-8030 Fax: 610-859-8030 |
News Archive
Teagasc research shows that loss of body fat causes the growth of the intestine and increases its capacity to absorb nutrients. This presents new approaches for weight management.
ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) today announced data from a Phase 1 clinical trial evaluating oral ridaforolimus, its investigational mTOR inhibitor, in combination with bevacizumab (AvastinĀ®) in heavily pretreated patients with refractory metastatic solid tumors. The data were presented at the Joint Multidisciplinary Congress of the 15th annual European Cancer Organization (ECCO) and the 34th annual European Society of Medical Oncology (ESMO) taking place in Berlin, Germany.
ZIOPHARM Oncology, Inc. announced today that Douglas J. Schwartzentruber, MD, FACS, of the Indiana University Health Goshen Center for Cancer Care, presented initial positive clinical results from the first-ever treatment demonstrating control over transgene encoding of a therapeutic anticancer protein in humans using a small molecule activator ligand.
Your immune system is always busy fighting incoming threats. It consists of a system of cells, and when there is a shortage of cells, it affects the performance of the immune system.
Women's eNews examines U.N.'s new agency U.N. Women, which officially got off the ground on Jan. 3. According to the news service, U.N. Women's "Manhattan headquarters remain unoccupied, said U.N. Women spokesperson Gretchen Luchsinger"; employees from the previous U.N. entities that focused on women's issues remain in "scattered offices around the U.N. Secretariat building"; and "[s]even high-level staff positions" remain unfilled.
› Verified 9 days ago